956 related articles for article (PubMed ID: 22213481)
21. Generation of induced pluripotent stem cells from virus-free in vivo reprogramming of BALB/c mouse liver cells.
de Lázaro I; Bussy C; Yilmazer A; Jackson MS; Humphreys NE; Kostarelos K
Biomaterials; 2014 Sep; 35(29):8312-20. PubMed ID: 25002261
[TBL] [Abstract][Full Text] [Related]
22. Different developmental potential of pluripotent stem cells generated by different reprogramming strategies.
Jiang J; Ding G; Lin J; Zhang M; Shi L; Lv W; Yang H; Xiao H; Pei G; Li Y; Wu J; Li J
J Mol Cell Biol; 2011 Jun; 3(3):197-9. PubMed ID: 21624975
[No Abstract] [Full Text] [Related]
23. The role of the reprogramming method and pluripotency state in gamete differentiation from patient-specific human pluripotent stem cells.
Mishra S; Kacin E; Stamatiadis P; Franck S; Van der Jeught M; Mertes H; Pennings G; De Sutter P; Sermon K; Heindryckx B; Geens M
Mol Hum Reprod; 2018 Apr; 24(4):173-184. PubMed ID: 29471503
[TBL] [Abstract][Full Text] [Related]
24. Serum starvation-induced cell cycle synchronization stimulated mouse rDNA transcription reactivation during somatic cell reprogramming into iPSCs.
Zhao Q; Wu Y; Shan Z; Bai G; Wang Z; Hu J; Liu L; Li T; Shen J; Lei L
Stem Cell Res Ther; 2016 Aug; 7(1):112. PubMed ID: 27515169
[TBL] [Abstract][Full Text] [Related]
25. Pluripotency, Differentiation, and Reprogramming: A Gene Expression Dynamics Model with Epigenetic Feedback Regulation.
Miyamoto T; Furusawa C; Kaneko K
PLoS Comput Biol; 2015 Aug; 11(8):e1004476. PubMed ID: 26308610
[TBL] [Abstract][Full Text] [Related]
26. Unrestricted somatic stem cells (USSC) from human umbilical cord blood display uncommitted epigenetic signatures of the major stem cell pluripotency genes.
Santourlidis S; Wernet P; Ghanjati F; Graffmann N; Springer J; Kriegs C; Zhao X; Brands J; Araúzo-Bravo MJ; Neves R; Koegler G; Uhrberg M
Stem Cell Res; 2011 Jan; 6(1):60-9. PubMed ID: 20933485
[TBL] [Abstract][Full Text] [Related]
27. Nuclear transcriptome profiling of induced pluripotent stem cells and embryonic stem cells identify non-coding loci resistant to reprogramming.
Fort A; Yamada D; Hashimoto K; Koseki H; Carninci P
Cell Cycle; 2015; 14(8):1148-55. PubMed ID: 25664506
[TBL] [Abstract][Full Text] [Related]
28. A plethora of human pluripotent stem cells.
Gao L; Thilakavathy K; Nordin N
Cell Biol Int; 2013 Sep; 37(9):875-87. PubMed ID: 23619972
[TBL] [Abstract][Full Text] [Related]
29. A hierarchy in reprogramming capacity in different tissue microenvironments: what we know and what we need to know.
Liebau S; Mahaddalkar PU; Kestler HA; Illing A; Seufferlein T; Kleger A
Stem Cells Dev; 2013 Mar; 22(5):695-706. PubMed ID: 23167697
[TBL] [Abstract][Full Text] [Related]
30. Metabolic remodeling during the loss and acquisition of pluripotency.
Mathieu J; Ruohola-Baker H
Development; 2017 Feb; 144(4):541-551. PubMed ID: 28196802
[TBL] [Abstract][Full Text] [Related]
31. Identification of the early and late responder genes during the generation of induced pluripotent stem cells from mouse fibroblasts.
Park J; Kwon YW; Ham S; Hong CP; Seo S; Choe MK; Shin SI; Lee CS; Kim HS; Roh TY
PLoS One; 2017; 12(2):e0171300. PubMed ID: 28152015
[TBL] [Abstract][Full Text] [Related]
32. Reprogramming somatic cells into pluripotent stem cells using miRNAs.
Anokye-Danso F
Methods Mol Biol; 2014; 1150():273-81. PubMed ID: 24744006
[TBL] [Abstract][Full Text] [Related]
33. Generation of transgene-free mouse induced pluripotent stem cells using an excisable lentiviral system.
Varga E; Nemes C; Davis RP; Ujhelly O; Klincumhom N; Polgar Z; Muenthaisong S; Pirity MK; Dinnyes A
Exp Cell Res; 2014 Apr; 322(2):335-44. PubMed ID: 24560743
[TBL] [Abstract][Full Text] [Related]
34. Global epigenetic changes during somatic cell reprogramming to iPS cells.
Mattout A; Biran A; Meshorer E
J Mol Cell Biol; 2011 Dec; 3(6):341-50. PubMed ID: 22044880
[TBL] [Abstract][Full Text] [Related]
35. Increased reprogramming capacity of mouse liver progenitor cells, compared with differentiated liver cells, requires the BAF complex.
Kleger A; Mahaddalkar PU; Katz SF; Lechel A; Joo JY; Loya K; Lin Q; Hartmann D; Liebau S; Kraus JM; Cantz T; Kestler HA; Zaehres H; Schöler H; Rudolph KL
Gastroenterology; 2012 Apr; 142(4):907-17. PubMed ID: 22245845
[TBL] [Abstract][Full Text] [Related]
36. [The alchemy--epigenetic regulation of pluripotency].
Bem J; Grabowska I
Postepy Biochem; 2013; 59(2):144-56. PubMed ID: 24044279
[TBL] [Abstract][Full Text] [Related]
37. Ground rules of the pluripotency gene regulatory network.
Li M; Belmonte JC
Nat Rev Genet; 2017 Mar; 18(3):180-191. PubMed ID: 28045100
[TBL] [Abstract][Full Text] [Related]
38. Live fluorescent RNA-based detection of pluripotency gene expression in embryonic and induced pluripotent stem cells of different species.
Lahm H; Doppler S; Dreßen M; Werner A; Adamczyk K; Schrambke D; Brade T; Laugwitz KL; Deutsch MA; Schiemann M; Lange R; Moretti A; Krane M
Stem Cells; 2015 Feb; 33(2):392-402. PubMed ID: 25335772
[TBL] [Abstract][Full Text] [Related]
39. From skin to the treatment of diseases--the possibilities of iPS cell research in dermatology.
Galach M; Utikal J
Exp Dermatol; 2011 Jun; 20(6):523-8. PubMed ID: 21585557
[TBL] [Abstract][Full Text] [Related]
40. [An overview of pluripotent stem cell lines].
Kieffer E; Kuntz S; Viville S
Med Sci (Paris); 2010 Oct; 26(10):848-54. PubMed ID: 20929676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
